Araştırma Makalesi
BibTex RIS Kaynak Göster

Preeclampsia: Current Approaches to Diagnosis and Nursing Management

Yıl 2018, Cilt: 4 Sayı: 2, 88 - 97, 29.06.2018

Ayşe Akalın Sevil Şahin

Öz

Preeclampsia is a dynamic, progressive, multisystem disorder of pregnancy. It ranks among leading cause of maternal and perinatal morbidity and mortality worldwide. Preeclampsia diagnosis includes on new onset of hypertension and proteinuria or hypertension and multiple organ dysfunction developing after 20 weeks’ gestation. Evidence based approaches available provide updated information on the assessment, prediction and management of preeclampsia. Nurses have a critical role in the diagnosis, evaluation and management of preeclampsia. This review article discusses the current knowledge on evidence-based in the management of preeclampsia and preeclampsia and the effect on nursing care.

Anahtar Kelimeler

preeclampsia pregnancy nursing care pregnancy complications clinical management

Kaynakça

  • 1. Pierre A, Zaharatos J, Goodman D, Callaghan, WM. Challenges and opportunities in identifying, reviewing, and preventing maternal deaths. Obstet gynecol 2018; 131: 138-42.
  • 2. Taşkın L. Riskli gebelikler. Doğum ve kadın sağlı hemşireliği. Akademisyen Yayınevi, 13. Baskı, Ankara, 2016: 243-50.
  • 3. Brown HL, Small MJ. Overview of maternal mortality and morbidity updated: Jan 2018. Erişim: 13 Mart 2018.
  • 4. T.C. Sağlık Bakanlığı (2016). Sağlık İstatistikleri Yıllığı 2016 Haber Bülteni. Sağlık Araştırmaları Genel Müdürlüğü, Ankara, 2017. Erişim: 13 Mart 2018, https://dosyasb.saglik.gov.tr/Eklenti/13183,sy2016turkcepdf. pdf?0
  • 5. WHO Maternal mortality Fact sheet Updated 2018 Erişim:8 Mart 2018 http://www.who.int/mediacentre/factsheets/fs348/en/
  • 6. Ferreira MB, Silveira CF, Silva SR, Souza DJ, et al. Nursing care for women with pre-eclampsia and/or eclampsia: Integrative review. Rev Esc Enferm USP 2016; 50: 324-34.
  • 7. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol 2013; 122: 1122-31 8. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183: 1-22.
  • 9. Koç İ, Schumacher R, Campbell O, Türkyılmaz S. et al. Üreme Sağlığı Programı Türkiye Ulusal Anne Ölümleri Çalışması 2005 Ana Rapor. Hacettepe Üniversitesi Nüfus Etütleri Enstitüsü. Elma Teknik Basım Matbaacılık, Ankara, 2005.
  • 10. World Health Organization (2005). The World Health Report. Make Every Mother and Child Count Geneva, World Health Organization. WHO Press, Genova, 2005.
  • 11. Say L, Chou D, Gemmill A, Tunçalp Ö, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health 2014; 2: 323–33
  • 12. Şencan İ, Engin-Üstün Y, Sanisoğlu S, Özcan A, et. al. 2014 yılı Türkiye ulusal anne ölümlerinin demografi k verilere göre değerlendirilmesi. J Gynecol Obstet Neonatal 2016; 13: 45-7.
  • 13. Keskinkılıç B. Engin-Üstün Y. Sanisoğlu S. Uygur DŞ, et al. Maternal mortality due to hypertensive disorders in pregnancy, childbirth, and the puerperium between 2012 and 2015 in Turkey: A nation-based study. J Turk Ger Gynecol Assoc 2017; 18: 20-5
  • 14. Peres MG, Mariana M. Cairrão E. Pre-Eclampsia and Eclampsia: An Update on the Pharmacological Treatment Applied in Portugal. J Cardiovasc Dev Dis 2018; 5: 2-13.
  • 15. Sava I, Keith L. March, Carl J. Hypertension in pregnancy: Taking cues from pathophysiology for clinical practice Pepine. Clinical Cardiology 2018; 41: 220-27.
  • 16. Çelik N. Saruhan A. Gebelikte riskli durumlar Editör: Sevil Ü, Ertem G. Perinataloji ve bakım, Ankara Nobel Tıp Kitabevleri, Ankara, 2016: 231-46.
  • 17. Phillips C, Boyd M. Assessment, management, and health implications of early-onset preeclampsia. Nurs Womens Health 2016; 20: 400-14.
  • 18. Ebbing C, Rasmussen S, Skjaerven R. Irgens LM. Risk factors for recurrence of hypertensive disorders of pregnancy, a population-based cohort study. Acta Obstet Gynecol Scand 2017; 96: 243-50.
  • 19. Bartsch E, Medcalf KE, Park AL, Ray JG, et al. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ 2016; 19: 353:i1753. doi: 10.1136/bmj.i1753.
  • 20. Kolialexi A, Mavreli D, Papantoniou N. Proteomics for early prenatal screening of pregnancy complications: A 2017 perspective. Expert Rev Proteomics 2017; 14: 113-15.
  • 21. Agency for Healthcare Research and Quality (AHRQ) (2017) Screening for Preeclampsia: A Systematic Evidence Review for the U.S. Preventive Services Task Force 2017 Report No: 14-05211-EF-1.
  • 22. Centers for Disease Control and Prevention (2017). Pregnancy mortality surveillance system. 2017. Erişim: 10 Mart 2018. https://www.cdc.gov/ reproductivehealth/maternalinfanthealth/pmss.html.
  • 23. American College of Obstetricians and Gynecologists (2016). Severe Maternal Morbidity: Screening and Review. Obstetric Care Consensus. Society for Maternal Fetal Medicine 2016; 5.
  • 24. Pinheiro TV, Brunetto S, Ramos JG, Bernardi JR, et al. Hypertensive disorders during pregnancy and health outcomes in the offspring: a systematic review. J Dev Orig Health Dis 2016; 7: 391-407.
  • 25. Anderson CM. Schmella MJ. Preeclampsia: Current Approaches to Nursing Management. Am J Nurs 2017; 117: 30-8
  • 26. Setty N, Kumar V, Srinivas BC, Reddy BN, et al. Approach to hypertensive disorders in pregnancy. Ann Clin Exp Hypertension 2016; 4: 1039.
  • 27. Duhig K, Vandermolen B, Shennan A. Recent advances in the diagnosis and management of pre-eclampsia. F1000Res. 7(F1000 Faculty Rev): 242 (doi: 10.12688/f1000research.12249.1).
  • 28. Norwitz ER. Repke JT. Preeclampsia: Management and prognosis 2018. Literature review current through: Feb 21, 2018. Erişim: 10 Mart 2018. https://www.uptodate.com/contents/preeclampsia-management-andprognosis
  • 29. Rumbold A, Ota E, Hori H, Miyazaki C, et al. Vitamin E supplementation in pregnancy. Cochrane Database Syst Rev 2015; 9: CD004069.
  • 30. Rumbold A, Ota E, Nagata C, Shahrook S, et al. Vitamin C supplementation in pregnancy. Cochrane Database Syst Rev 2015; 9: CD004072.
  • 31. Pretorius T, Rensburg G, Dyer RA, Biccard BM. The infl uence of fl uid management on outcomes in preeclampsia: a systematic review and meta-analysis. Int J Obstet Anesth. 2018 https://doi.org/10.1016/j. ijoa.2017.12.004
  • 32. El-Sayed YY, Borders AE, Committee on Obstetric Practice. Committee opinion no. 692: Emergent theraphy for acute-onset severe hipertansion during pregnancy and the postpartum period. Obstet Gynecol 2017; 129: 90-5.
  • 33. Atallah A, Lecarpentier E, Goffi net F, et al. Aspirin for prevention of preeclampsia. Drugs 2017; 77: 1819–31.
  • 34. Magro-Malosso ER, Saccone G, Tommaso MD, et al. Exercise during pregnancy and risk of gestational hypertensive disorders: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 2017; 96: 921–31.
  • 35. Brookfi eld KF, Su F, Elkomy MH, Drover DR, et al. Pharmacokinetics and placental transfer of magnesium sulfate in pregnant women. Am J Obstet Gynecol 2016; 214: 737.e1-9.
  • 36. Rimal SP, Rijal P, Bhatt R, Thapa K. Loading dose only versus Standard dose magnesium sulfate seizure prophylaxis in severe pre-eclamptic women. NMA J Nepal Med Assoc. 2017; 56: 388-94.
  • 37. Amorim MM, Souza ASR, Katz L. Planned caesarean section versus planned vaginal birth for severe pre-eclampsia. Cochrane Database Syst Rev. 2017; 23: 10:CD009430. doi: 10.1002/14651858.CD009430.pub2.
  • 38. Cairns AE, Pealing L, Duffy JMN, Roberts N, et al. Postpartum management of hypertensive disorders of pregnancy: A systematic review. BMJ Open 2017; 7: doi:10.1136/bmjopen-2017-018696.
  • 39. Ditisheim A, Wuerzner G, Ponte B, et al. Prevalence of hypertensive phenotypes after preeclampsia: a prospective cohort study. Hypertension. 2018; 71: 103–9.

Preeklampsi: Tanı ve Hemşirelik Yönetiminde Güncel Yaklaşımlar

Yıl 2018, Cilt: 4 Sayı: 2, 88 - 97, 29.06.2018

Ayşe Akalın Sevil Şahin

Öz

Preeklampsi gebeliğin dinamik, progresif ve tüm sistemleri etkileyen bir hastalığıdır. Dünya çapında ise maternal ve perinatal morbidite ve mortalitenin önde gelen nedenleri arasında yer almaktadır. Preeklampside tanı, 20. gebelik haftasından sonra gelişen yeni başlangıçlı hipertansiyon ve proteinüri veya hipertansiyon ve çoklu organ fonksiyon bozukluğunu kapsamaktadır. Kanıt temelli yaklaşımlar, preeklampsinin öngörülmesi, değerlendirilmesi ve yönetimine ilişkin güncel bilgiler sağlamaktadır. Preeklampsinin tanılanması, değerlendirilmesi ve yönetiminde ise hemşirelerin önemli bir rolü bulunmaktadır. Bu derleme makalede, preeklampsi ve preeklampsi yönetiminde kanıta dayalı güncel bilgiler ve hemşirelik bakımına etkisi tartışılmıştır

Anahtar Kelimeler

preeklampsi gebelik hemşirelik bakımı gebelik komplikasyonları klinik yönetim

Kaynakça

  • 1. Pierre A, Zaharatos J, Goodman D, Callaghan, WM. Challenges and opportunities in identifying, reviewing, and preventing maternal deaths. Obstet gynecol 2018; 131: 138-42.
  • 2. Taşkın L. Riskli gebelikler. Doğum ve kadın sağlı hemşireliği. Akademisyen Yayınevi, 13. Baskı, Ankara, 2016: 243-50.
  • 3. Brown HL, Small MJ. Overview of maternal mortality and morbidity updated: Jan 2018. Erişim: 13 Mart 2018.
  • 4. T.C. Sağlık Bakanlığı (2016). Sağlık İstatistikleri Yıllığı 2016 Haber Bülteni. Sağlık Araştırmaları Genel Müdürlüğü, Ankara, 2017. Erişim: 13 Mart 2018, https://dosyasb.saglik.gov.tr/Eklenti/13183,sy2016turkcepdf. pdf?0
  • 5. WHO Maternal mortality Fact sheet Updated 2018 Erişim:8 Mart 2018 http://www.who.int/mediacentre/factsheets/fs348/en/
  • 6. Ferreira MB, Silveira CF, Silva SR, Souza DJ, et al. Nursing care for women with pre-eclampsia and/or eclampsia: Integrative review. Rev Esc Enferm USP 2016; 50: 324-34.
  • 7. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol 2013; 122: 1122-31 8. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183: 1-22.
  • 9. Koç İ, Schumacher R, Campbell O, Türkyılmaz S. et al. Üreme Sağlığı Programı Türkiye Ulusal Anne Ölümleri Çalışması 2005 Ana Rapor. Hacettepe Üniversitesi Nüfus Etütleri Enstitüsü. Elma Teknik Basım Matbaacılık, Ankara, 2005.
  • 10. World Health Organization (2005). The World Health Report. Make Every Mother and Child Count Geneva, World Health Organization. WHO Press, Genova, 2005.
  • 11. Say L, Chou D, Gemmill A, Tunçalp Ö, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health 2014; 2: 323–33
  • 12. Şencan İ, Engin-Üstün Y, Sanisoğlu S, Özcan A, et. al. 2014 yılı Türkiye ulusal anne ölümlerinin demografi k verilere göre değerlendirilmesi. J Gynecol Obstet Neonatal 2016; 13: 45-7.
  • 13. Keskinkılıç B. Engin-Üstün Y. Sanisoğlu S. Uygur DŞ, et al. Maternal mortality due to hypertensive disorders in pregnancy, childbirth, and the puerperium between 2012 and 2015 in Turkey: A nation-based study. J Turk Ger Gynecol Assoc 2017; 18: 20-5
  • 14. Peres MG, Mariana M. Cairrão E. Pre-Eclampsia and Eclampsia: An Update on the Pharmacological Treatment Applied in Portugal. J Cardiovasc Dev Dis 2018; 5: 2-13.
  • 15. Sava I, Keith L. March, Carl J. Hypertension in pregnancy: Taking cues from pathophysiology for clinical practice Pepine. Clinical Cardiology 2018; 41: 220-27.
  • 16. Çelik N. Saruhan A. Gebelikte riskli durumlar Editör: Sevil Ü, Ertem G. Perinataloji ve bakım, Ankara Nobel Tıp Kitabevleri, Ankara, 2016: 231-46.
  • 17. Phillips C, Boyd M. Assessment, management, and health implications of early-onset preeclampsia. Nurs Womens Health 2016; 20: 400-14.
  • 18. Ebbing C, Rasmussen S, Skjaerven R. Irgens LM. Risk factors for recurrence of hypertensive disorders of pregnancy, a population-based cohort study. Acta Obstet Gynecol Scand 2017; 96: 243-50.
  • 19. Bartsch E, Medcalf KE, Park AL, Ray JG, et al. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ 2016; 19: 353:i1753. doi: 10.1136/bmj.i1753.
  • 20. Kolialexi A, Mavreli D, Papantoniou N. Proteomics for early prenatal screening of pregnancy complications: A 2017 perspective. Expert Rev Proteomics 2017; 14: 113-15.
  • 21. Agency for Healthcare Research and Quality (AHRQ) (2017) Screening for Preeclampsia: A Systematic Evidence Review for the U.S. Preventive Services Task Force 2017 Report No: 14-05211-EF-1.
  • 22. Centers for Disease Control and Prevention (2017). Pregnancy mortality surveillance system. 2017. Erişim: 10 Mart 2018. https://www.cdc.gov/ reproductivehealth/maternalinfanthealth/pmss.html.
  • 23. American College of Obstetricians and Gynecologists (2016). Severe Maternal Morbidity: Screening and Review. Obstetric Care Consensus. Society for Maternal Fetal Medicine 2016; 5.
  • 24. Pinheiro TV, Brunetto S, Ramos JG, Bernardi JR, et al. Hypertensive disorders during pregnancy and health outcomes in the offspring: a systematic review. J Dev Orig Health Dis 2016; 7: 391-407.
  • 25. Anderson CM. Schmella MJ. Preeclampsia: Current Approaches to Nursing Management. Am J Nurs 2017; 117: 30-8
  • 26. Setty N, Kumar V, Srinivas BC, Reddy BN, et al. Approach to hypertensive disorders in pregnancy. Ann Clin Exp Hypertension 2016; 4: 1039.
  • 27. Duhig K, Vandermolen B, Shennan A. Recent advances in the diagnosis and management of pre-eclampsia. F1000Res. 7(F1000 Faculty Rev): 242 (doi: 10.12688/f1000research.12249.1).
  • 28. Norwitz ER. Repke JT. Preeclampsia: Management and prognosis 2018. Literature review current through: Feb 21, 2018. Erişim: 10 Mart 2018. https://www.uptodate.com/contents/preeclampsia-management-andprognosis
  • 29. Rumbold A, Ota E, Hori H, Miyazaki C, et al. Vitamin E supplementation in pregnancy. Cochrane Database Syst Rev 2015; 9: CD004069.
  • 30. Rumbold A, Ota E, Nagata C, Shahrook S, et al. Vitamin C supplementation in pregnancy. Cochrane Database Syst Rev 2015; 9: CD004072.
  • 31. Pretorius T, Rensburg G, Dyer RA, Biccard BM. The infl uence of fl uid management on outcomes in preeclampsia: a systematic review and meta-analysis. Int J Obstet Anesth. 2018 https://doi.org/10.1016/j. ijoa.2017.12.004
  • 32. El-Sayed YY, Borders AE, Committee on Obstetric Practice. Committee opinion no. 692: Emergent theraphy for acute-onset severe hipertansion during pregnancy and the postpartum period. Obstet Gynecol 2017; 129: 90-5.
  • 33. Atallah A, Lecarpentier E, Goffi net F, et al. Aspirin for prevention of preeclampsia. Drugs 2017; 77: 1819–31.
  • 34. Magro-Malosso ER, Saccone G, Tommaso MD, et al. Exercise during pregnancy and risk of gestational hypertensive disorders: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 2017; 96: 921–31.
  • 35. Brookfi eld KF, Su F, Elkomy MH, Drover DR, et al. Pharmacokinetics and placental transfer of magnesium sulfate in pregnant women. Am J Obstet Gynecol 2016; 214: 737.e1-9.
  • 36. Rimal SP, Rijal P, Bhatt R, Thapa K. Loading dose only versus Standard dose magnesium sulfate seizure prophylaxis in severe pre-eclamptic women. NMA J Nepal Med Assoc. 2017; 56: 388-94.
  • 37. Amorim MM, Souza ASR, Katz L. Planned caesarean section versus planned vaginal birth for severe pre-eclampsia. Cochrane Database Syst Rev. 2017; 23: 10:CD009430. doi: 10.1002/14651858.CD009430.pub2.
  • 38. Cairns AE, Pealing L, Duffy JMN, Roberts N, et al. Postpartum management of hypertensive disorders of pregnancy: A systematic review. BMJ Open 2017; 7: doi:10.1136/bmjopen-2017-018696.
  • 39. Ditisheim A, Wuerzner G, Ponte B, et al. Prevalence of hypertensive phenotypes after preeclampsia: a prospective cohort study. Hypertension. 2018; 71: 103–9.
Toplam 38 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Konular Sağlık Kurumları Yönetimi
Bölüm Derleme
Yazarlar

Ayşe Akalın Bu kişi benim

Sevil Şahin

Yayımlanma Tarihi 29 Haziran 2018
Gönderilme Tarihi 14 Mart 2018
Kabul Tarihi 23 Mayıs 2018
Yayımlandığı Sayı Yıl 2018 Cilt: 4 Sayı: 2

Kaynak Göster

APA Akalın, A., & Şahin, S. (2018). Preeklampsi: Tanı ve Hemşirelik Yönetiminde Güncel Yaklaşımlar. Journal of Human Rhythm, 4(2), 88-97.
AMA Akalın A, Şahin S. Preeklampsi: Tanı ve Hemşirelik Yönetiminde Güncel Yaklaşımlar. Journal of Human Rhythm. Haziran 2018;4(2):88-97.
Chicago Akalın, Ayşe, ve Sevil Şahin. “Preeklampsi: Tanı Ve Hemşirelik Yönetiminde Güncel Yaklaşımlar”. Journal of Human Rhythm 4, sy. 2 (Haziran 2018): 88-97.
EndNote Akalın A, Şahin S (01 Haziran 2018) Preeklampsi: Tanı ve Hemşirelik Yönetiminde Güncel Yaklaşımlar. Journal of Human Rhythm 4 2 88–97.
IEEE A. Akalın ve S. Şahin, “Preeklampsi: Tanı ve Hemşirelik Yönetiminde Güncel Yaklaşımlar”, Journal of Human Rhythm, c. 4, sy. 2, ss. 88–97, 2018.
ISNAD Akalın, Ayşe - Şahin, Sevil. “Preeklampsi: Tanı Ve Hemşirelik Yönetiminde Güncel Yaklaşımlar”. Journal of Human Rhythm 4/2 (Haziran 2018), 88-97.
JAMA Akalın A, Şahin S. Preeklampsi: Tanı ve Hemşirelik Yönetiminde Güncel Yaklaşımlar. Journal of Human Rhythm. 2018;4:88–97.
MLA Akalın, Ayşe ve Sevil Şahin. “Preeklampsi: Tanı Ve Hemşirelik Yönetiminde Güncel Yaklaşımlar”. Journal of Human Rhythm, c. 4, sy. 2, 2018, ss. 88-97.
Vancouver Akalın A, Şahin S. Preeklampsi: Tanı ve Hemşirelik Yönetiminde Güncel Yaklaşımlar. Journal of Human Rhythm. 2018;4(2):88-97.